TG
LLY icon

TCW Group’s Eli Lilly LLY Stock Holding History

TCW Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
13,163
+20
+0.2% +$20.3K 0.09% 129
2025
Q4 		$14.1M Buy
+13,143
New +$12.6M 0.1% 119
2025
Q3 		– Sell
-22,799
Closed -$17.8M – 308
2025
Q2 		$17.8M Buy
22,799
+8,596
+61% +$6.68M 0.14% 109
2025
Q1 		$11.7M Buy
14,203
+1,614
+13% +$1.34M 0.11% 123
2024
Q4 		$9.72M Buy
12,589
+1,011
+9% +$837K 0.08% 140
2024
Q3 		$10.3M Sell
11,578
-275
-2% -$247K 0.09% 131
2024
Q2 		$10.7M Buy
11,853
+468
+4% +$374K 0.1% 130
2024
Q1 		$8.86M Sell
11,385
-1,976
-15% -$1.41M 0.09% 135
2023
Q4 		$7.76M Buy
+13,361
New +$7.8M 0.09% 146
2021
Q2 		– Sell
-17,458
Closed -$3.26M – 352
2021
Q1 		$3.26M Sell
17,458
-4,550
-21% -$890K 0.03% 226
2020
Q4 		$3.72M Hold
22,008
– – 0.03% 208
2020
Q3 		$3.26M Hold
22,008
– – 0.04% 196
2020
Q2 		$3.61M Sell
22,008
-511
-2% -$78.4K 0.04% 178
2020
Q1 		$3.12M Hold
22,519
– – 0.04% 180
2019
Q4 		$2.96M Hold
22,519
– – 0.03% 190
2019
Q3 		$2.52M Hold
22,519
– – 0.03% 191
2019
Q2 		$2.5M Sell
22,519
-620
-3% -$73K 0.03% 196
2019
Q1 		$3M Sell
23,139
-1,147
-5% -$139K 0.03% 187
2018
Q4 		$2.81M Sell
24,286
-1,856
-7% -$207K 0.03% 198
2018
Q3 		$2.81M Buy
26,142
+206
+0.8% +$20.6K 0.02% 204
2018
Q2 		$2.21M Sell
25,936
-11,317
-30% -$930K 0.02% 218
2018
Q1 		$2.88M Buy
37,253
+1,079
+3% +$86.9K 0.02% 197
2017
Q4 		$3.06M Sell
36,174
-1,691
-4% -$144K 0.02% 193
2017
Q3 		$3.24M Sell
37,865
-1,904
-5% -$156K 0.03% 196
2017
Q2 		$3.27M Buy
39,769
+14,936
+60% +$1.22M 0.03% 203
2017
Q1 		$2.09M Sell
24,833
-71,650
-74% -$5.74M 0.02% 231
2016
Q4 		$7.1M Buy
96,483
+14,583
+18% +$1.09M 0.05% 168
2016
Q3 		$6.57M Buy
81,900
+3,750
+5% +$300K 0.05% 166
2016
Q2 		$6.15M Sell
78,150
-13,594
-15% -$1.02M 0.05% 168
2016
Q1 		$6.61M Buy
91,744
+16,694
+22% +$1.26M 0.05% 167
2015
Q4 		$6.32M Buy
75,050
+950
+1% +$78.8K 0.05% 171
2015
Q3 		$6.2M Buy
74,100
+1,750
+2% +$148K 0.04% 168
2015
Q2 		$6.04M Sell
72,350
-211,815
-75% -$16.1M 0.04% 210
2015
Q1 		$20.6M Buy
284,165
+9,915
+4% +$706K 0.1% 157
2014
Q4 		$18.9M Sell
274,250
-207,350
-43% -$14M 0.08% 170
2014
Q3 		$31.2M Sell
481,600
-11,950
-2% -$757K 0.13% 153
2014
Q2 		$30.7M Buy
493,550
+4,050
+0.8% +$242K 0.13% 160
2014
Q1 		$28.8M Sell
489,500
-700
-0.1% -$39.1K 0.12% 154
2013
Q4 		$25M Buy
490,200
+600
+0.1% +$30K 0.11% 161
2013
Q3 		$24.6M Buy
489,600
+3,450
+0.7% +$181K 0.11% 151
2013
Q2 		$23.9M Buy
+486,150
New +$26.5M 0.12% 155

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TCW Group's LLY Position: Q1 2026 in Review

TCW Group increased its Eli Lilly (LLY) stake by 0.15% in Q1 2026, buying an estimated $20.3K and bringing the position to 13,163 shares worth $12.1M. The position accounts for 0.09% of the portfolio, ranked #129.

TCW Group first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. The position peaked at $31.2M in Q3 2014. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • TCW Group held 13,163 shares of Eli Lilly worth $12.1M as of Q1 2026.
  • TCW Group bought 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
  • Eli Lilly made up 0.09% of TCW Group's portfolio in Q1 2026, its #129 holding.
  • TCW Group first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
  • TCW Group's Eli Lilly position peaked at $31.2M in Q3 2014.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.